Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilect in Idiopathic Parkinson's Disease
NCT00399477Phase 4Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Oct 2006
- Primary completion
- Jul 2007
- Modality
- Irreversible Covalent Inhibitors
01
Overview
A Phase 4 trial of rasagiline in Parkinson's disease (PD), sponsored by Teva Pharmaceutical Industries Ltd.. Started Oct 2006; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00399477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00399477.